N*****d
发帖数: 9872 | 1 05:49 PM EST, 02/07/2017 (MT Newswires) -- Gilead Sciences (GILD) declined
in Tuesday's after-hours trade after topping Q4 expectations but also
detailing hepatitis C drug sales guidance below expectations.
GILD touched a brief, early after-hours high of 75 before sliding to a
negative range of 72.99 to 69.20, where it stayed through the bulk of night
trade. A pre-market open Wednesday may have legs surrounding the 69.50 mark.
Sell momentum was consistent Tuesday night at 71 to 70, levels where
traders may want to watch for a potential near-term ceiling to form early on
Wednesday. |
|
